[Retracted] Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer

Table 6

Multivariate analysis of the mean prognosis survival time of CRC patients.

Variables	B	SE	Walds		OR	95% CI
Pathological grade	1.447	0.502	8.309	0.014	4.250	1.368–7.526
Peritoneal metastasis	1.602	0.533	9.034	0.008	4.963	1.861–8.035
Chemotherapy regimen	−0.459	0.641	5.181	0.102	0.632	0.226–1.015